TOP 1288

Drug Profile

TOP 1288

Alternative Names: TOP-1288

Latest Information Update: 16 Mar 2017

Price : $50

At a glance

  • Originator TopiVert
  • Class Anti-inflammatories; Small molecules
  • Mechanism of Action Protein kinase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Ulcerative colitis

Most Recent Events

  • 08 Feb 2017 Phase-I clinical trials in Ulcerative colitis (In volunteers) in United Kingdom (PO) (NCT03071081)
  • 01 Sep 2016 Phase-II clinical trials in Ulcerative colitis in Ukraine (Rectal) (NCT02888379)
  • 05 Jul 2016 Phase-II clinical trials in Ulcerative colitis in Lithuania (Rectal) (EudraCT2016-000390-20)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top